1. Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy. (11th July 2019) Authors: Mandell, Jonathan B.; Lu, Feiqi; Fisch, Matthew; Beumer, Jan H.; Guo, Jianxia; Watters, Rebecca J.; Weiss, Kurt R. Other Names: Jeon Dae-Geun Academic Editor. Journal: Sarcoma Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Issue 11 (4th September 2019) Authors: Takebe, Naoko; Beumer, Jan H.; Kummar, Shivaani; Kiesel, Brian F.; Dowlati, Afshin; O'Sullivan Coyne, Geraldine; Piekarz, Richard; Rubinstein, Lawrence; Fogli, Laura K.; Vaishampayan, Ulka; Goel, Sanjay; O'Bryant, Cindy L.; El‐Rayes, Bassel F.; Chung, Vincent; Lenz, Heinz‐Josef; Kim, Richard; Bel... Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 11(2019) Page Start: 2499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain. Issue 4 (21st February 2022) Authors: Singh, Vinita; Gillespie, Theresa W.; Lane, Olabisi; Spektor, Boris; Zarrabi, Ali John; Egan, Katherine; Curseen, Kimberly; Tsvetkova, Maya; Beumer, Jan H.; Sniecinski, Roman; Shteamer, Jack W.; Switchenko, Jeffery; Harvey, R. Donald Journal: Pharmacotherapy Issue: Volume 42:Issue 4(2022) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ALDH1A1 Gene Expression and Cellular Copper Levels between Low and Highly Metastatic Osteosarcoma Provide a Case for Novel Repurposing with Disulfiram and Copper. (28th January 2022) Authors: Mandell, Jonathan B.; Douglas, Nerone; Ukani, Vrutika; Beumer, Jan H.; Guo, Jianxia; Payne, John; Newman, Rebecca; Mancinelli, Luigi; Intini, Giuseppe; Anderson, Carolyn J.; Watters, Rebecca; Weiss, Kurt Other Names: Honoki Kanya Academic Editor. Journal: Sarcoma Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy. Issue 3 (11th September 2018) Authors: Beumer, Jan H.; Chu, Edward; Allegra, Carmen; Tanigawara, Yusuke; Milano, Gerard; Diasio, Robert; Kim, Tae Won; Mathijssen, Ron H.; Zhang, Li; Arnold, Dirk; Muneoka, Katsuki; Boku, Narikazu; Joerger, Markus Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 3(2019) Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quantitation of the ataxia‐telangiectasia‐mutated and Rad3‐related inhibitor elimusertib (BAY‐1895344) in human plasma using LC–MS/MS. (8th August 2022) Authors: Kiesel, Brian F.; Parise, Robert A.; Krishnamurthy, Anuradha; Gore, Steven; Beumer, Jan H. Journal: Biomedical chromatography Issue: Volume 36:Number 11(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Issue 7 (10th March 2015) Authors: Lassman, Andrew B.; Pugh, Stephanie L.; Gilbert, Mark R.; Aldape, Kenneth D.; Geinoz, Sandrine; Beumer, Jan H.; Christner, Susan M.; Komaki, Ritsuko; DeAngelis, Lisa M.; Gaur, Rakesh; Youssef, Emad; Wagner, Henry; Won, Minhee; Mehta, Minesh P. Journal: Neuro-oncology Issue: Volume 17:Issue 7(2015:Jul.) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation. (19th September 2015) Authors: Beumer, Jan H.; Pillai, Venkateswaran C.; Parise, Robert A.; Christner, Susan M.; Kiesel, Brian F.; Rudek, Michelle A.; Venkataramanan, Raman Journal: British journal of clinical pharmacology Issue: Volume 80:Number 5(2015:Nov.) Page Start: 1097 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. Issue 2 (28th January 2020) Authors: Siddiqi, Tanya; Frankel, Paul; Beumer, Jan H.; Kiesel, Brian F.; Christner, Susan; Ruel, Chris; Song, Joo Y.; Chen, Robert; Kelly, Kevin R.; Ailawadhi, Sikander; Kaesberg, Paul; Popplewell, Leslie; Puverel, Sandrine; Piekarz, Richard; Forman, Stephen J.; Newman, Edward M. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 2(2020) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring. Issue 3 (June 2017) Authors: Kozo, Daniel; Ross, Matt W.; Jarrah, Justin; Barrett, Michael; Harney, Rebecca L.; Courtney, Jodi B.; Baburina, Irina; Holleran, Julianne L.; Beumer, Jan H.; Peters, Godefridus J.; Honeywell, Richard J.; Salamone, Salvatore J. Journal: Therapeutic drug monitoring Issue: Volume 39:Issue 3(2017:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗